What is the recommended total‑intravenous anesthetic regimen of propofol combined with remifentanil for burr‑hole surgery?

Recommended TIVA Regimen for Burr-Hole Surgery

For burr-hole surgery, use propofol combined with remifentanil as a total intravenous anesthetic (TIVA) regimen, with propofol for induction at 0.5-1.0 mg/kg IV bolus followed by 75-100 mcg/kg/min infusion, and remifentanil at 1 mcg/kg bolus over 30-60 seconds followed by 0.25-0.5 mcg/kg/min infusion, titrated to hemodynamic response.

Induction Protocol

Propofol:

• Initial bolus: 0.5-1.0 mg/kg IV 1
• Follow with continuous infusion at 75-100 mcg/kg/min 1, 2

Remifentanil:

• Initial bolus: 1 mcg/kg over 30-60 seconds 2, 3
• Initial infusion: 0.5-1.0 mcg/kg/min 2
• This higher initial rate effectively controls responses to intubation 3

Maintenance Protocol

After intubation, reduce remifentanil infusion by 50% to 0.25-0.5 mcg/kg/min 2, 3. The combination demonstrates synergistic effects, meaning you need less of each drug than if used alone 4.

Key dosing principles:

• Propofol: Maintain at 75-100 mcg/kg/min (can use target-controlled infusion if available) 1
• Remifentanil: Titrate between 0.25-0.5 mcg/kg/min based on surgical stimulus 2, 3
• For transient intense surgical stress, give supplemental remifentanil boluses of 1 mcg/kg every 2-5 minutes 2

Synergistic Interaction

The propofol-remifentanil combination is synergistic, not merely additive 4. As propofol concentrations increase from 2 to 7.3 mcg/ml, the required remifentanil concentration decreases dramatically—from 3.8 ng/ml to essentially 0 ng/ml for laryngoscopy 4. This means you can use substantially lower doses of both agents compared to monotherapy, reducing side effects while maintaining adequate anesthesia depth.

Monitoring Requirements

• Continuous arterial blood pressure monitoring (consider arterial line for burr-hole procedures) 5
• Pulse oximetry
• Capnography
• ECG
• Consider BIS monitoring to avoid excessive anesthetic depth, particularly in elderly patients 1

Critical Safety Considerations

Respiratory depression risk: The propofol-remifentanil combination produces deeper sedation and more respiratory depression than either agent alone 6. Maintain airway control throughout the procedure.

Cardiovascular effects:

• Hypotension occurs in 10-30% of patients during induction and maintenance 3, 7
• Bradycardia occurs in 7-19% of patients, more common with higher remifentanil doses 3
• Have vasopressors immediately available
• Consider atropine pretreatment to blunt bradycardia 2

Muscle rigidity: Occurs in 6-7% of patients at induction with remifentanil 7. Administer neuromuscular blocking agents as needed.

Emergence and Recovery

Rapid emergence is a hallmark of this combination 3, 8, 9:

• Time to eye opening: 5-7 minutes 8, 7
• Time to extubation: 5-10 minutes 2, 8
• Recovery is predictable and independent of infusion duration 2

Critical transition point: Remifentanil provides no residual analgesia after discontinuation 10, 2. Administer longer-acting analgesics (morphine 0.1-0.15 mg/kg IV) approximately 20 minutes before anticipated end of surgery 2. This does not delay respiratory recovery when properly timed 2.

Advantages for Neurosurgical Procedures

This TIVA regimen is particularly suited for burr-hole surgery because:

• Minimal effects on intracranial pressure 11
• Rapid, predictable emergence allowing immediate neurological assessment 9
• Reduced operative time compared to volatile anesthetics in neurosurgical procedures (104 vs 129 minutes in glioblastoma surgery) 9
• Propofol shows no significant pharmacokinetic alterations even in patients with hepatic or renal dysfunction 11, 12

Dose Adjustments

Elderly patients: Reduce propofol induction dose; consider lower maintenance rates 11

Obese patients: Dose propofol based on ideal body weight, not actual weight 11

Hepatic dysfunction: Fentanyl is safer than morphine; remifentanil clearance is unaffected by hepatic disease 11

Common Pitfalls to Avoid

1. Inadequate transition analgesia: Failing to administer longer-acting opioids before remifentanil discontinuation leads to severe pain and hypertension upon emergence
2. Excessive initial dosing: The synergistic interaction means standard doses of each agent will cause profound hypotension and bradycardia
3. Bolus administration during spontaneous ventilation: Causes transient apnea and muscle rigidity 2
4. Ignoring context-sensitive half-time: Remifentanil's 3-minute context-sensitive half-time means effects dissipate within minutes of stopping infusion 3, 13